In a study of 40 mice, scientists find that the CB2-selective agonist significantly reduced the severity of arthritis and markedly reduced bone erosion. These data clearly indicate that the CB2-selective agonist may be considered a novel treatment for rheumatoid arthritis.
A selective CB2 agonist protects against the inflammatory response and joint destruction in collagen-induced arthritis miceDownload
